Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses
  2. Mytle, Nutan; Leyrer, Sonja; Inglefield,Jon; Harris, Andrea M; Hickey,Thomas; Minang, Jacob; Lu, Hang; Ma, Zhidong; Andersen, Hanné; Grubaugh, Nathan D; Guina, Tina; Skiadopoulos, Mario H; Lacy, Michael J
  3. Viruses. 2021, Aug 27; 13(9):
  1. 2.   Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route
  2. Johnson, R. F.; Dyall, J.; Ragl, D. R.; Huzella, L.; Byrum, R.; Jett, C.; St Claire, M.; Smith, A. L.; Paragas, J.; Blaney, J. E.; Jahrling, P. B.
  3. Journal of Virology. 2011, Mar; 85(5): 2112-2125.
  1. 3.   Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCR alpha beta(+) CD8 alpha beta(+) T cells in the small intestinal mucosa
  2. Isakov, D.; Dzutsev, A.; Belyakov, I. M.; Berzofsky, J. A.
  3. Mucosal Immunology. 2009 2(5): 450-461.
  1. 4.   Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
  2. Thorne, S. H.; Hwang, T. H. H.; O'Gorman, W. E.; Bartlett, D. L.; Sei, S.; Kanji, F.; Brown, C.; Werier, J.; Cho, J. H.; Lee, D. E.; Wang, Y.; Bell, J.; Kirn, D. H.
  3. Journal of Clinical Investigation. 2007, Nov; 117(11): 3350-3358.
  1. 5.   DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  2. Nigam, P.; Earl, P. L.; Americo, J. L.; Sharma, S.; Wyatt, L. S.; Edghill-Spano, Y.; Chennareddi, L. S.; Silvera, P.; Moss, B.; Robinson, H. L.; Amara, R. R.
  3. Virology. 2007, Sep; 366(1): 73-83.
  1. 6.   Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  2. Earl, P. L.; Americo, J. L.; Wyatt, L. S.; Eller, L. A.; Montefiori, D. C.; Byrum, R.; Piatak, M.; Lifson, J. D.; Amara, R. R.; Robinson, H. L.; Huggins, J. W.; Moss, B.
  3. Virology. 2007, Sep; 366(1): 84-97.
  1. 7.   Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus
  2. Kaur, A.; Sanford, H. B.; Garry, D.; Lang, S.; Klumpp, S. A.; Watanabe, D.; Bronson, R. T.; Lifson, J. D.; Rosati, M.; Pavlakis, G. N.; Felber, B. K.; Knipe, D. M.; Desrosiers, R. C.
  3. Virology. 2007, Jan; 357(2): 199-214.
  1. 8.   Overproduction, purification, and biochemical characterization of the dual specificity H1 protein phosphatase encoded by variola major virus
  2. Tropea, J. E.; Phan, J.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, Nov; 50(1): 31-36.
  1. 9.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 10.   The differential ability of HLA b*5701(+) long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences
  2. Migueles, S. A.; Laborico, A. C.; Imamichi, H.; Shupert, W. L.; Royce, C.; McLaughlin, M.; Ehler, L.; Metcalf, J.; Liu, S. Y.; Hallahan, C. W.; Connors, M.
  3. Journal of Virology. 2003 77(12): 6889-6898.
  1. 11.   Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques
  2. Patterson, L. J.; Peng, B.; Abimiku, A. G.; Aldrich, K.; Murty, L.; Markham, P. D.; Kalyanaraman, V. S.; Alvord, W. G.; Tartaglia, J.; Franchini, G.; Robert-Guroff, M.
  3. Aids. 2000 14(16): 2445-2455.
  1. 12.   N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
  2. Chabot, D. J.; Chen, H.; Dimitrov, D. S.; Broder, C. C.
  3. Journal of Virology. 2000 74(9): 4404-4413.
  1. 13.   Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses
  2. Dey, B.; Lerner, D. L.; Lusso, P.; Boyd, M. R.; Elder, J. H.; Berger, E. A.
  3. Journal of Virology. 2000 74(10): 4562-4569.
  1. 14.   Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: Effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses
  2. Kumar, A.; Lifson, J. D.; Silverstein, P. S.; Jia, F.; Sheffer, D.; Li, Z.; Narayan, O.
  3. Virology. 2000 274(1): 149-164.
  1. 15.   A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
  2. Dimitrov, D. S.; Norwood, D.; Stantchev, T. S.; Feng, Y. R.; Xiao, X. D.; Broder, C. C.
  3. Virology. 1999 259(1): 1-6.
  1. 16.   Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in macaques
  2. Polacino, P. S.; Stallard, V.; Klaniecki, J. E.; Pennathur, S.; Montefiori, D. C.; Langlois, A. J.; Richardson, B. A.; Morton, W. R.; Benveniste, R. E.; Hu, S. L.
  3. Journal of Virology. 1999 73(10): 8201-8215.
  1. 17.   Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120
  2. Esser, M. T.; Mori, T.; Mondor, I.; Sattentau, Q. J.; Dey, B.; Berger, E. A.; Boyd, M. R.; Lifson, J. D.
  3. Journal of Virology. 1999 73(5): 4360-4371.
  1. 18.   Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
  2. Robinson, H. L.; Montefiori, D. C.; Johnson, R. P.; Manson, K. H.; Kalish, M. L.; Lifson, J. D.; Rizvi, T. A.; Lu, S.; Hu, S. L.; Mazzara, G. P.; Panicali, D. L.; Herndon, J. G.; Glickman, R.; Candido, M. A.; Lydy, S. L.; Wyand, M. S.; McClure, H. M.
  3. Nature Medicine. 1999 5(5): 526-534.
  1. 19.   Sequence Diversity of Sivmne Nef in Vivo and in Vitro
  2. Heidecker, G.; Munoz, H.; Lloyd, P. A.; Hodge, D. R.; Pei, G. K.; Rick, S. W.; Brehm, K.; Ruscetti, F. W.; Kuller, L.; Polacino, P.; Hu, S. L.; Morton, W. R.; Benveniste, R. E.
  3. Journal of Medical Primatology. 1998 27(2-3): 73-80.
  1. 20.   Influence of the Ccr2-V64i Polymorphism On Human Immunodeficiency Virus Type 1 Coreceptor Activity and On Chemokine Receptor Function of Ccr2b, Ccr3, Ccr5, and Cxcr4
  2. Lee, B.; Doranz, B. J.; Rana, S.; Yi, Y. J.; Mellado, M.; Frade, J. M. R.; Martinez, C.; Obrien, S. J.; Dean, M.; Collman, R. G.; Doms, R. W.
  3. Journal of Virology. 1998 72(9): 7450-7458.
  1. 21.   A Novel Human Erk Phosphatase Regulates H-Ras and V-Raf Signal Transduction
  2. Shin, D. Y.; Ishibashi, T.; Choi, T. S.; Chung, E. M.; Chung, I. Y.; Aaronson, S. A.; Bottaro, D. P.
  3. Oncogene. 1997 14(22): 2633-2639.
  1. 22.   Thioltransferase (Glutaredoxin) Is Detected-Within Hiv-1 and Can Regulate the Activity of Glutathionylated Hiv-1 Protease in Vitro
  2. Davis, D. A.; Newcomb, F. M.; Starke, D. W.; Ott, D. E.; Mieyal, J. J.; Yarchoan, R.
  3. Journal of Biological Chemistry. 1997 272(41): 25935-25940.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel